Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03350724 · ClinicalTrials.gov registry record · NA
Patient Outcomes and Gingival Blood Flow Using Laser Doppler Flowmetry Following the Use of Episil on Free Gingival Graft Donor Sites
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT03350724 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 34 participants.
The verdict
NCT03350724, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The hypothesis for the present study is that patient-based outcomes and gingival blood flow will be more favorable for the free gingival graft (FGG) donor sites being covered by the test wound dressing material episil compared to the control dressing.
Interventions
- DEVICE episil wound dressing
- DEVICE PeriAcryl90 wound dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2015-10-29 |
| Est. Completion | 2017-05-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03350724
The ClinicalTrials.gov registry entry for NCT03350724 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which episil wound dressing is the first listed.
NCT03350724 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03350724 about?
NCT03350724 is a clinical study titled "Patient Outcomes and Gingival Blood Flow Using Laser Doppler Flowmetry Following the Use of Episil on Free Gingival Graft Donor Sites". The hypothesis for the present study is that patient-based outcomes and gingival blood flow will be more favorable for the free gingival graft (FGG) donor sites being covered by the test wound dressing material episil compared to the control dressing.
What is the current status of trial NCT03350724?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2015-10-29. Estimated completion is 2017-05-19.
What interventions are being tested in trial NCT03350724?
The interventions under investigation include: episil wound dressing (DEVICE), PeriAcryl90 wound dressing (DEVICE).
Who is sponsoring clinical trial NCT03350724?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.